Arkadios Wealth Advisors Purchases New Holdings in Core Scientific, Inc. (NASDAQ:CORZ)

Arkadios Wealth Advisors purchased a new stake in shares of Core Scientific, Inc. (NASDAQ:CORZ) in the third quarter, HoldingsChannel.com reports. The institutional investor purchased 10,042 shares of the company’s stock, valued at approximately $119,000.

A number of other large investors also recently bought and sold shares of the business. Rise Advisors LLC lifted its position in Core Scientific by 14.3% during the 3rd quarter. Rise Advisors LLC now owns 8,000 shares of the company’s stock valued at $95,000 after acquiring an additional 1,000 shares during the period. Banque Cantonale Vaudoise purchased a new position in Core Scientific during the 2nd quarter valued at about $28,000. Sunbelt Securities Inc. purchased a new position in Core Scientific during the 2nd quarter valued at about $33,000. Vontobel Holding Ltd. raised its holdings in Core Scientific by 10.4% in the third quarter. Vontobel Holding Ltd. now owns 38,089 shares of the company’s stock worth $452,000 after buying an additional 3,591 shares during the last quarter. Finally, Aspect Partners LLC purchased a new position in Core Scientific in the first quarter worth about $29,000.

Insider Activity at Core Scientific

In related news, CFO Denise Marie Brucia Sterling sold 8,752 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total transaction of $82,356.32. Following the completion of the sale, the chief financial officer now directly owns 122,217 shares in the company, valued at approximately $1,150,061.97. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Core Scientific news, CFO Denise Marie Brucia Sterling sold 8,752 shares of Core Scientific stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total transaction of $82,356.32. Following the transaction, the chief financial officer now owns 122,217 shares of the company’s stock, valued at $1,150,061.97. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Todd M. Duchene sold 11,582 shares of Core Scientific stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total transaction of $108,986.62. Following the transaction, the insider now directly owns 1,686,474 shares in the company, valued at $15,869,720.34. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders acquired 12,761 shares of company stock worth $127,080. 32.00% of the stock is owned by company insiders.

Core Scientific Trading Down 2.0 %

Shares of CORZ stock opened at $13.03 on Friday. The company has a 50 day moving average price of $11.91 and a 200-day moving average price of $8.98. Core Scientific, Inc. has a 52 week low of $2.61 and a 52 week high of $14.64.

Core Scientific (NASDAQ:CORZ) last announced its earnings results on Wednesday, August 7th. The company reported ($4.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($4.47). The company had revenue of $141.10 million for the quarter, compared to the consensus estimate of $128.58 million. Core Scientific’s revenue for the quarter was up 11.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Core Scientific, Inc. will post 0.81 EPS for the current year.

Wall Street Analysts Forecast Growth

CORZ has been the subject of several recent analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $20.00 target price on shares of Core Scientific in a report on Thursday, October 3rd. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $17.00 target price on shares of Core Scientific in a report on Tuesday, September 10th. Needham & Company LLC lifted their target price on shares of Core Scientific from $16.00 to $17.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. HC Wainwright lifted their target price on shares of Core Scientific from $11.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Finally, Jefferies Financial Group initiated coverage on shares of Core Scientific in a report on Monday, October 28th. They issued a “buy” rating and a $19.00 target price for the company. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Core Scientific has an average rating of “Buy” and an average target price of $16.71.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.